Annual Review

2020: A year of solidarity, partnerships, trust and empathy

Scroll for more

Our
purpose

We have an active and crucial role
in raising standards of everyday life,
in making people healthier,
happier and safer.

Letter to the
Shareholders

The stable relationships of the Group with employees, partners and investors, local communities and authorities, built over time with great care and attention, helped a lot to maintain the market position of companies, jobs and gave us the opportunity to be most useful to society in times of crisis.

Read more

Key indicators

Sopharma group

In 2020 SOPHARMA GROUP registered 12.3% growth in sales revenue

1438826

(+12.3%)

BGN '000 Revenues from sales

45800

(-23.3%)

BGN '000 Operating profit

92433

(-10.9%)

BGN '000 EBITDA

25280

(-70.0%)

BGN '000 Net profit

Sopharma AD

2020 tested our flexibility and our capability to achieve relative security in times of great turbulence. We saved jobs, kept promises, maintained partnerships.

206737

(-10.38%)

BGN '000 Revenues from sales

32823

(-28.70%)

BGN '000 Operating profit

51053

(-20.71%)

BGN '000 EBITDA

28664

(-29.02%)

BGN '000 Net profit

Key financial indicators
Sopharma group

BGN '000 2020 2019 2018
Revenues from sales 1 438 826 1 281 587 1 179 143
EBITDA 92 433 103 696 72 278
Operating profit 45 800 59 692 39 143
Net profit 25 280 84 359 30 637
EBITDA/ sales revenues 6.4% 8.1% 6.1%
Operating profit/ sales revenues 3.2% 4.7% 3.3%
Net debt/ EBITDA an annual basis 4.30x 4.68x 4.15x
Attracted capital/ Equity 1.19 1.04 0.99

“Sopharma” AD

BGN '000 2020 2019 2018
Revenues from sales 206 737 230 691 212 418
EBITDA 51 053 64 385 45 212
Operating profit 32 823 46 038 27 798
Net profit 28 664 40 382 33 298
EBITDA/ sales revenues 24.70% 27.9% 21.3%
Operating profit/ sales revenues 15.90% 20.0% 13.1%
Net debt/ EBITDA an annual basis 1.5x 1.7x 1.6x
Attracted capital/ Equity 0.21 0.30 0.24

REVENUE BREAKDOWN BY SEGMENTS IN 2020

PORTFOLIO OF PRODUCTS BY THERAPEUTIC GROUPS IN 2020

GEOGRAPHICAL SPLIT IN 2020

Environment, Social activity and Management

To ensure the fulfillment of its mission, Sopharma Group constantly invests in production - new technologies, research and development; in increasing the efficiency of distribution; in maintaining an active and effective dialogue with all participants in the healthcare system; in participation in significant projects and programs related to the development of society and in environmental protection.

5163

EMPLOYEES IN 2019

741

DONATIONS in 2019

BGN '000

5803

EMPLOYEES IN 2020

962

DONATION IN 2020

BGN '000

Environment, Social activity and Management

993061

REVENUES FROM SALES OF GOODS IN 2019

BGN ‘000 (+7.0%)

288526

REVENUES FROM SALES OF PRODUCTS IN 2019

BGN ‘000 (+15.0%)

1168870

REVENUES FROM SALES OF GOODS IN 2020

BGN ‘000 (+18.0%)

269956

REVENUES FROM SALES OF PRODUCTS IN 2020

BGN ‘000 (-6.0%)

Environment, Social activity and Management

7.2%

OF REVENUES FROM SALES OF PRODUCTS IN 2019

RAW MATERIALS

5.3%

OF REVENUES FROM SALES OF PRODUCTS IN 2020

RAW MATERIALS

MANAGEMENT TEAM

63%

Women

37%

Men

PROFILE AND
STRATEGY OF
THE COMPANY

Established pharmaceutical producer and reliable partner
with almost 90 years of history

Values
& commitment

Our values

2020
AT A
GLANCE

“SOPHARMA” AD
on the stock
exchange

Download
center